A phase I/II trial of capecitabine combined with peginterferon α-2a in Patients with sorafenib-refractory advanced hepatocellular carcinoma

✍ Scribed by Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Kanogawa, Naoya; Motoyama, Tenyu; Suzuki, Eiichiro; Tawada, Akinobu; Kanai, Fumihiko; Yokosuka, and Osamu

• Book ID: 125358942
• Publisher: Springer US
• Year: 2014
• Tongue: English
• Weight: 248 KB
• Volume: 32
• Category: Article
• ISSN: 0167-6997
• DOI: 10.1007/s10637-014-0097-2